Dr. Mookerjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 Acorn Park Drive
Cambridge, MA 02140Phone+1 856-261-0153- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1991 - 1994
- ArMed Forces Medical College PuneClass of 1987
Certifications & Licensure
- PA State Medical License 2001 - 2024
- MD State Medical License 1994 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Clinical Trials
- Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation Start of enrollment: 2000 Oct 01
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 2000 Jan 01
- AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 96 citationsRegulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.Xiang-Nong Luo, Bijoyesh Mookerjee, A. Ferrari, Sucharita J. Mistry, George F. Atweh> ;The Journal of Biological Chemistry. 1994 Apr 8
- 42 citationsLong-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.Axel Hauschild, Paolo A. Ascierto, Dirk Schadendorf, Jean-Jacques Grob, Antoni Ribas, Felix Kiecker, Caroline Dutriaux, Lev V. Demidov, Céleste Lebbé, Piotr Rutkowski,...> ;European Journal of Cancer. 2020 Jan 1
- 31 citationsDabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 ...G V Long, K T Flaherty, D Stroyakovskiy, H Gogas, E Levchenko, F de Braud, J Larkin, C Garbe, T Jouary, A Hauschild, V Chiarion-Sileni, C Lebbe, M Mandalá, M Millward,...> ;Annals of Oncology. 2019 Nov 1
- Join now to see all
Press Mentions
- Two Combination Therapies Shrink Melanoma Brain Metastases in More Than Half of PatientsJune 4th, 2017
Professional Memberships
- Member
- European Society of Medical OncologyMember
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: